AzTrials
AzTrials

Problem GamblingNCT06561139

Mindfulness as an add-on Intervention in Treatment for Problem Gambling in Clinical Settings in Sweden

A study testing Mindfulness in people with Problem Gambling, run by Region Skane at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will test the effects of an add-on mindfulness intervention for patients with gambling problems, added to treatment as usual, compared to a waitlist control condition. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Problem Gambling
What is being tested?
Mindfulness
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSweden
Study dates
15 Aug 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Enrolled in any kind of treatment for problem gambling at a regional health care unit for problem gambling or at any municipal social service unit for problem gambling, and who provides informed consent

Who cannot join

  • Inability to provide informed consent due to language difficulties or due to severe mental health problems, or because of mental health problems requiring urgent psychiatric management (such as suicidal, homicidal, delirious or psychotic behavior)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anders Håkansson, PhD contact

+46 46 175596

anders_c.hakansson@med.lu.se

Patrick Bacquin, nurse contact

patrick.bacquin@skane.se

Sweden1 site, 1 recruiting
  • Malmö Addiction Center

    Malmö

    Anders Håkansson, PhD, anders.c.hakansson@skane.se

    Malin Åkesson, secr, malin.L.akesson@skane.se

    Recruiting

Other trials in Sweden

About this study

Official title: Mindfulness as an add-on Intervention in Treatment for Problem Gambling - a Randomized Control Trial and a Qualitative Analysis in Clinical Settings in Sweden

This study will test the effects of an add-on mindfulness intervention for patients with gambling problems, added to treatment as usual, compared to a waitlist control condition. The study will primarily aim to decrease gambling behaviour compared to the control condition which receives the intervention later, after two months, and secondarily to decrease symptoms of depressive and anxiety symptoms. In addition, patients who have undergone the mindfulness intervention will be offered participation in a qualitative interview study aiming to deepen the understanding of feasibility and challenges of a mindfulness add-on intervention against gambling problems.

Being tested
Mindfulness
Keywords
Problem gambling, Mindfulness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MindfulnessBehavioural

    Weekly group sessions of mindfulness, for eight weeks

Study groups in NCT06561139
Study groupRoleWhat they receive
Intervention: treatment as usual + group mindfulnessExperimentalEight-week, weekly group sessions of mindfulness, as an add-on to treatment as usual for problem gambling.
Receives: Behavioral: Mindfulness
Control: treatment as usual + waiting list for two monthsActive comparatorTreatment as usual for problem gambling and waiting list for the mindfulness condition for two months, after which subjects are offered to undergo the same intervention as in the intervention group.
Receives: Behavioral: Mindfulness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in past 30-day gambling (NODS 30 days)

    Change in the number of criteria met according to a diagnostic tool for gambling disorder, but measuring the past 30 days at baseline and at post-treatment, and 3 and 12 months post-treatment

    Measured: Post-treatment (treatment completion) and 3 and 12 months after end of treatment

Secondary outcomes (2)
  1. Change in past-2-week depressive symptoms

    Change in scores on Patient Health Questionnaire-9, a well-recognised instrument measuring past-2-week depressive symptoms

    Measured: Post-treatment (treatment completion) and 3 and 12 months after end of treatment

  2. Change in past-2-week anxiety symptoms

    Change in scores on Generalised Anxiety Disorder-7, a well-recognised instrument measuring past-2-week anxiety symptoms

    Measured: Post-treatment (treatment completion) and 3 and 12 months after end of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2024
  2. Study start15 Aug 2024
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized control trial, and subsequently a qualitative study
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06561139
Sponsor's protocol ID
Mindfulness gambling study
Status last verified
Aug 2024
First submitted
16 Aug 2024
Last updated
21 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness in people with Problem Gambling, run by Region Skane at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anders Håkansson, PhD (+46 46 175596, anders_c.hakansson@med.lu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in past 30-day gambling (NODS 30 days) (time frame: Post-treatment (treatment completion) and 3 and 12 months after end of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in